(2S,5S)-tert-butyl 5-(3-bromo-5-((diethoxyphosphoryl)methyl)benzyl)-2-(tert-butyl)-3-methyl-4-oxoimidazolidine-1-carboxylate, 98%, 50mg

7-BROMO-4,4-DIMETHYL-3,4-DIHYDRONAPHTHALEN-1(2H)-ONE, 95.0%, 1g

Potassium Oxonate>98.0%(HPLC)(T)25g

4-Bromo-2-ethoxythiazole, 95.0%, 10g

Methyl 6-fluoro-2-oxoindoline-5-carboxylate, 98%, 250mg

2-Fluoroethanamine hydrochloride, 97.00%, 50g

2-(3-Bromophenyl)-2-oxoacetic acid, 95.0%, 5g

(S)-2-((tert-butoxycarbonyl)amino)-3-(3-chloro-4-hydroxyphenyl)propanoic acid, 98%, 100mg

6-(Methoxycarbonyl)pyrimidine-4-carboxylic acid, 95%, 250mg

bScope BS.1153-EPLPHi para contraste de fases. Triocular con oculares HWF 10x/20 mm y revólver quíntuple E-plan Phase IOS 10/20/S40 S100x

(2S,4R)-1-(tert-Butoxycarbonyl)-4-(methylamino)pyrrolidine-2-carboxylic acid, 98%, 1g

1-pyrrolidino-2-isocyanoacetamide, 98%, 1g

N-Butyrylglycine, 95%, 50mg